TRPS1 expression in breast carcinoma and its relationship with Er, Pr, Her2 neu and other clinicopathological parameters

Background : TRPS1 is a transcription factor with prominent expression in mammary epithelial cells and has attracted interest as a potential biomarker in breast carcinoma. This study assessed TRPS1 immunoreactivity and examined its relationship with hormone-receptor status and selected clinicopathological characteristics. Materials and Methods : A hospital-based cross-sectional observational study was undertaken in the Department of Pathology, Sri Guru Ramdas Institute of Medical Sciences and Research, from July 2024 through December 2025. Fifty-two histologically confirmed breast carcinoma cases represented by mastectomy specimens were evaluated. Immunohistochemical staining for TRPS1, ER, PR and HER2neu was performed on formalin-fixed, paraffin-embedded tissue. Associations between categorical variables were assessed with the chi-square test or Fisher's exact test, with statistical significance defined as p≤0.05. Results : The patients had a mean age of 54.44 years, with ages ranging from 29 to 80 years. Tumors measuring 2–5 cm constituted 71.2% of cases, while 61.5% were histological grade III. ER, PR and HER2neu positivity were identified in 42.3%, 32.7% and 26.9% of cases, respectively. TRPS1 was positive in 44 of 52 cases (84.6%). TRPS1 expression showed significant relationships with histological grade (p=0.015), lymphovascular invasion (p=0.042), ER status (p=0.008), PR status (p=0.032), and combined ER/PR status (p=0.031). No statistically significant relationship was demonstrated with HER2 neu, age, tumor size or lymph-node status. Conclusion : In this cohort, TRPS1 expression was frequent and was associated particularly with hormone-receptor positivity and lower tumor grade. TRPS1 may therefore have value as an adjunctive marker in the assessment of breast carcinoma, although larger studies with longer follow-up are required.

Authors

Publication Details

Journal
Indian Journal of Pathology and Oncology
Published
2026-11-16
DOI
https://doi.org/10.18231/j.ijpo.18588.1793256300
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

TRPS1 expression in breast carcinoma and its relationship with Er, Pr, Her2 neu and other clinicopathological parameters

Menka Khanna, Karamjit S. Gill, Tanvir Kaur Saini, Ishaan Khanna et al.
2 links
Indian Journal of Pathology and Oncology
Breast Cancer Treatment Studies
article

TRPS1 expression in breast carcinoma and its relationship with Er, Pr, Her2 neu and other clinicopathological parameters

Menka Khanna, Karamjit S. Gill, Tanvir Kaur Saini, Ishaan Khanna, Arpanpreet Kaur Bhinder
article en

Abstract

Background : TRPS1 is a transcription factor with prominent expression in mammary epithelial cells and has attracted interest as a potential biomarker in breast carcinoma. This study assessed TRPS1 immunoreactivity and examined its relationship with hormone-receptor status and selected clinicopathological characteristics. Materials and Methods : A hospital-based cross-sectional observational study was undertaken in the Department of Pathology, Sri Guru Ramdas Institute of Medical Sciences and Research, from July 2024 through December 2025. Fifty-two histologically confirmed breast carcinoma cases represented by mastectomy specimens were evaluated. Immunohistochemical staining for TRPS1, ER, PR and HER2neu was performed on formalin-fixed, paraffin-embedded tissue. Associations between categorical variables were assessed with the chi-square test or Fisher's exact test, with statistical significance defined as p≤0.05. Results : The patients had a mean age of 54.44 years, with ages ranging from 29 to 80 years. Tumors measuring 2–5 cm constituted 71.2% of cases, while 61.5% were histological grade III. ER, PR and HER2neu positivity were identified in 42.3%, 32.7% and 26.9% of cases, respectively. TRPS1 was positive in 44 of 52 cases (84.6%). TRPS1 expression showed significant relationships with histological grade (p=0.015), lymphovascular invasion (p=0.042), ER status (p=0.008), PR status (p=0.032), and combined ER/PR status (p=0.031). No statistically significant relationship was demonstrated with HER2 neu, age, tumor size or lymph-node status. Conclusion : In this cohort, TRPS1 expression was frequent and was associated particularly with hormone-receptor positivity and lower tumor grade. TRPS1 may therefore have value as an adjunctive marker in the assessment of breast carcinoma, although larger studies with longer follow-up are required.

Indian Journal of Pathology and OncologyVol. 13(4)
Good health and well-being
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon